COMMUNIQUÉ DE PRESSE publié le 22/05/2025 à 07:00, il y a 1 année 2 mois Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 Relief Therapeutics granted FDA Rare Pediatric Disease Designation for RLF-TD011 in treating epidermolysis bullosa, a rare genetic skin disorder. Potent antimicrobial & anti-inflammatory activity shown FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease Designation
BRÈVE publiée le 15/05/2025 à 07:05, il y a 1 année 2 mois Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
BRÈVE publiée le 15/05/2025 à 07:05, il y a 1 année 2 mois Relief Therapeutics annonce l'ordre du jour de l'assemblée générale annuelle 2025 États Financiers Assemblée Générale Annuelle Réélection Du Conseil D'administration Vote Des Actionnaires Approbation De L'indemnisation
COMMUNIQUÉ DE PRESSE publié le 15/05/2025 à 07:00, il y a 1 année 2 mois Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics announces agenda for its 2025 Annual General Meeting featuring key resolutions and re-elections. Meeting scheduled for June 12 in Geneva, Switzerland Shareholders Switzerland Relief Therapeutics Agenda 2025 Annual General Meeting
BRÈVE publiée le 10/04/2025 à 07:05, il y a 1 année 4 mois Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
BRÈVE publiée le 10/04/2025 à 07:05, il y a 1 année 4 mois Relief Therapeutics annonce ses résultats financiers et ses progrès stratégiques pour 2024 Biopharmaceutique Maladies Rares THÉRAPEUTIQUE DE SECOURS Résultats Financiers 2024 Progrès Du Pipeline
COMMUNIQUÉ DE PRESSE publié le 10/04/2025 à 07:00, il y a 1 année 4 mois Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRÈVE publiée le 06/03/2025 à 07:05, il y a 1 année 5 mois Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
BRÈVE publiée le 06/03/2025 à 07:05, il y a 1 année 5 mois Relief Therapeutics met fin aux discussions de fusion avec Renexxion Valeur Actionnariale Objectifs Stratégiques THÉRAPEUTIQUE DE SECOURS Renexxion Fin De La Fusion
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 5 mois Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
Publié le 10/08/2026 à 18:00, il y a 7 minutes AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Publié le 10/08/2026 à 18:00, il y a 7 minutes AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Publié le 10/08/2026 à 11:53, il y a 6 heures 13 minutes GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Publié le 10/08/2026 à 15:30, il y a 2 heures 37 minutes Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Publié le 10/08/2026 à 15:25, il y a 2 heures 42 minutes Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Publié le 10/08/2026 à 14:30, il y a 3 heures 37 minutes NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Publié le 10/08/2026 à 13:30, il y a 4 heures 37 minutes Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Publié le 10/08/2026 à 13:00, il y a 5 heures 7 minutes Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Publié le 10/08/2026 à 17:50, il y a 17 minutes Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Publié le 10/08/2026 à 17:38, il y a 29 minutes PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026
Publié le 10/08/2026 à 17:11, il y a 56 minutes CORRECTION FROM SOURCE: North Peak Commences 2026 Drilling Campaign at Prospect Mountain, Eureka, Nevada
Publié le 10/08/2026 à 16:12, il y a 1 heure 55 minutes dK Calls on PANDION AG Bondholders to Join Forces
Publié le 10/08/2026 à 15:56, il y a 2 heures 11 minutes Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
